Literature DB >> 22690739

Influenza type A virus: an outstandingly protean pathogen and a potent modular weapon.

Dany Shoham1.   

Abstract

A remarkable debate recently arose on a global scale, about bioethics, biohazard, bioweaponry and bioterrorism issues related to scientific research concerning the induced transition of the highly lethal H5N1 avian flu virus from a non-pandemic to a tentatively pandemic strain, which might fall into malevolent hands. Appreciable ecogenetic complexity marks the main attributes of influenza type A viruses, namely infectivity, virulence, antigenicity, transmissibility, host range, endemicity, and epidemicity. They all shape, conjunctively, the outstanding protean nature of this pathogen, hence the modularity of the latter as a potent weapon. The present analysis inquires into those attributes, so as to profile and gauge threat, usability, impact and coping, particularly that the dimension of genetic engineering of this virus largely amplifies its potential. Within that context, various human interventions and misuses, including human experimental infections, undesirable vaccinations, as well as unauthorized and unskillful operations, led to bad corollaries and are also discussed in the present study. Altogether, a variety of interrelated properties underlying the complicatedness of and menaces posed by influenza A virus as a grave medical challenge, a dually explorable pathogen, and a modular biological warfare agent, are thereby illuminated, alongside with their scientific, strategic and practical implications.

Entities:  

Mesh:

Year:  2012        PMID: 22690739     DOI: 10.3109/1040841X.2012.692355

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  1 in total

1.  Development of a magnetic electrochemical bar code array for point mutation detection in the H5N1 neuraminidase gene.

Authors:  Ludmila Krejcova; David Hynek; Pavel Kopel; Miguel Angel Merlos Rodrigo; Vojtech Adam; Jaromir Hubalek; Petr Babula; Libuse Trnkova; Rene Kizek
Journal:  Viruses       Date:  2013-07-15       Impact factor: 5.048

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.